top of page

A Creative Approach to Deal-Making for Small

and Mid-Sized Government Contractors

By Senior Managing Director, Robert Rubin

ree

Current market conditions are having a profound impact on the value of small and mid-sized government contractors. The macro factors impacting the industry present major challenges to sustaining growth, maintaining profitability and enhancing enterprise value.

When forced to confront the reality of survival, a sale at currently depressed prices, though unappealing, may seem to be the only viable option available to produce any value for shareholders. However, is this the only option? We believe that there are other options for small and mid-sized government contractors (revenues up to $50 million) to not only survive, but thrive, and position themselves for a significant enhancement in shareholder value.

Though the fundamentals of government contracting may still be more attractive than many other sectors of the economy, continuing to do business the same way increases the risk of becoming marginalized and experiencing a potentially slow and possibly long decline.


The Forgotten M in M&A

Historically there has been a much greater volume of “A” acquisition than “M” merger activity. For purposes of this article, the term merger is being used in the strategic and business context. A discussion of some of the legal issues that arise will also be examined later in this article. Acquisitions tend to be more straightforward as the parties agree on a purchase price and terms and at the closing the buyer assumes authority over management, decision making and issues impacting the corporate culture. In contrast, a merger is a “union of two or more entities into one” – where integrating the operating and cultural needs of the parties into a workable environment becomes a more collaborative effort.

Resolving the most basic elements of a transaction, such as valuation and ownership control, can be significantly more difficult and time consuming in a merger. In spite of these additional complications, we are seeing increased activity in merger transactions for small and mid-sized government contractors as a practical response to current market conditions where valuations have experienced a significant decline.


Recent Merger Activity

Let’s look at a real life example to understand how a merger works.

ABC is a $50 million government contractor providing high end engineering services including simulation and training to customers throughout the Department of Defense (DoD). The majority of their business is in the intelligence community. Until recently, ABC experienced double digit revenue growth and profit margins. Beginning in 2016, however, as customer budgets declined, the movement toward larger contract awards and schedules and increased pressure to become a subcontractor, ABC experienced a significant slowdown in new business awards resulting in flat revenue growth and a 33% decline in profit margins. In the near term the Company implemented actions to stabilize profit margins by selectively reducing their fixed cost structure. To be able to compete for larger contract awards and return to historical levels of growth and profitability, senior management identified the need to achieve greater critical mass-- $100 million revenue. To reach this target in the next 3-5 years, will likely require a combination of organic growth supplemented by multiple strategic acquisitions. While ABC had excess cash and the availability of bank debt to complete these transactions, they were concerned that taking on the leverage necessary to complete these transactions could have a significant negative impact on their financial flexibility.


In their search, ABC met Company XYZ which had $10 million in revenues. Much of their business was concentrated in the intel space and most of their people had high level clearances. Both parties saw a strong business case as there was little overlap of customers and skills and identified opportunities to leverage a wider range of skills across a large customer base. Just as importantly, the senior management of both companies hit it off and shared many of the same basic beliefs and culture. In addition, there was little redundancy and opportunities to rationalize the back office. Owner of XYZ wanted to stay on for some time after a transaction.

Great chemistry, great business case, ABC did not want to take on the debt that was going to be required to complete this transaction—what to do? A transaction structured with some cash to seller at closing and the remainder of the purchase consideration of stock in ABC provided the seller with a nice amount of cash at closing and the incentive to continue to work hard for the combined entity.


What this created:

  • More critical mass—a 20% increase in revenues and increased level of profitability

  • Greater opportunity for the combined entity—identified numerous opportunities that they could not have gone after on their own

  • The opportunity to come up with a more competitive cost structure—while there were few headcount reductions, spreading ABC’s G&A and OH structure across a wider revenue base resulted in a more competitive cost structure. Immediately becoming more competitive

  • Expansion of management team to include owner of XYZ.

  • Articulation of common goals and exit strategy which reduces a lot of the risk associated with a transaction

  • The ability to complete the transaction without crippling the balance sheet with debt


Keys for Success

An important factor for success in a merger is the development of detailed strategic and operating plans which incorporate clearly identified and measurable financial goals and milestones, specific management responsibilities, and an agreed upon exit strategy. While the keys to a successful merger entail many of the same strategic considerations as an acquisition, other considerations which require serious examination include:

  • Compatibility of corporate cultures

  • Alignment of management structure and style

  • Agreement on long term shareholder goals and expectations

  • Initial valuation of both enterprises

  • Structuring of corporate governance

  • Mechanism for resolving major issues that arise

  • Agreement on exit horizon


The importance of these issues and the time required to reach agreement should not be minimized, and can be even more complicated where a private equity firm or financial owner is involved. If done correctly, however, the success of any transaction is greatly enhanced.

M&A the same old way? Not likely! With continued pressure on growth and profit margins, small and mid-sized government contractors are going to have to be more flexible and creative in accumulating the resources to realize their full potential. Companies and investors with the financial resources and fresh approaches to creating value will may be handsomely rewarded with transformational opportunities at prices not seen in the market for years.

Completing a merger requires a broad skill set to address the many challenges that a straight acquisition does not. The principles of Boustead Securities, LLC have the unique combination of M&A, financial and operational skills to accomplish these transactions.

If you would like to discuss how a merger or an acquisition can impact your company, please contact me at:


Robert Rubin

301.537.8221




About Robert N. Rubin

Robert Rubin joined Boustead as Senior Managing Director in 2020 and has over 35 years of experience in Mergers and Acquisitions, the last 25 of which have been specifically focused on the technical services marketplace including Aerospace, Defense and Government contracting in the Washington DC Metropolitan area. In addition to his background in M&A, he has extensive experience in corporate finance and development with public and privately held companies. He has been involved in more than 40 transactions worldwide, and served as President of the National Capital Chapter and on the International Board of Directors for ACG. Robert is a FINRA registered representative and holds series 7, 24, 63, 79 and 99 licenses. For more information on M&A's contact: Robert Rubin (301) 537-8221 Robert.Rubin@boustead1828.com



About Boustead Securities, LLC

Boustead Securities, LLC (“Boustead”) is an investment banking firm that executes and advises on IPOs, mergers and acquisitions, capital raises and restructuring assignments in a wide array of industries, geographies and transactions, for a broad client base. Boustead’s core value proposition is the ability to create opportunity through innovative solutions and tenacious execution. With experienced professionals in the United States, Boustead’s team moves quickly and provides a broad spectrum of sophisticated financial advice and services. Boustead is a majority owned subsidiary of Boustead & Company Limited, a diversified non-bank financial institution. For more information, please visit www.boustead1828.com.

Form CRS/Reg BI Disclaimer:

Boustead Securities, LLC is registered with the Securities and Exchange Commission (SEC) as a broker-dealer and is a member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC). Brokerage and investment advisory services and fees differ and it is important for you to understand these differences. Free and simple tools are available to research firms and financial professionals at Investor.gov/CRS, which also provides educational materials about broker-dealers, investment advisers, and investing. When we provide you with a recommendation, we have to act in your best interest and not put our interest ahead of yours. At the same time, the way we make money creates a conflict with your interests. Please strive to understand and ask us about these conflicts because they can affect the recommendations we provide you. There are many risks involved with investing. For Boustead Securities customers and clients, please see our Regulation Best Interest Relationship Guide on the Form CRS Reg BI page on our website at https://www.boustead1828.com/form-crs-reg-bi. For Sutter Securities’ and Sutter Securities Clearing’s customers and clients, please see the Form CRS on the website at https://suttersecurities.com/wp-content/uploads/2020/12/Sutter-Form-CRS-combined-121020.pdf. For FlashFunders’ visitors, you may review the Form CRS of Boustead Securities, Sutter Securities and Sutter Securities Clearing under the Form CRS section. Please also carefully review and verify the accuracy of the information you provide us on account applications, subscription documents and others.

Cautionary Statement Concerning Forward-Looking Statements

This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this document and other statements made from time to time by us or our representatives might not occur.

Predictive Health Diagnostics $10M Pre-IPO Offering

Management Q&A Webinar This Tuesday, February 16th, at 1:00 PM PT

ree

Boustead Securities, LLC (“Boustead”) presents its latest Pre-IPO offering, Predictive Health Diagnostics (“PHD”). PHD combines science, technology, proprietary analytics and clinical studies to detect cardiovascular disease and diabetes when it can be treated or more easily prevented.

Their Protein Unstable Lesion Signature Cardiac Test (“PULS Test”) measures protein biomarkers that indicate damage to the lining of the arteries – believed to be the earliest sign of coronary artery disease. The serum blood test helps to find people that are at risk of having a heart attack in the next 5 Years. PHD’s proprietary AI technology allows them to contemporaneously evaluate multiple relevant data types to identify clinically useful relationships that may be undetected by conventional methods. In 2016, PULS Test was the winner of the AABY Award for Innovation in Healthcare.


WEBINAR

Please join Doug Harrington, Founder and Chairman, and Matthew Nunez, CEO, for a Q&A Webinar this Tuesday, February 16th at 1:00 PM PT as they discuss how they can detect early forms of cardiovascular disease and diabetes.


Predictive Health Diagnostics Webinar

Tuesday, February 16th

1:00 PM PT


ree

About Predictive Health Diagnostics

PHD develops, manufactures, and distributes unique diagnostic tests that can detect the early forms of cardiovascular disease and diabetes. Their PULS Test measures protein biomarkers that indicate damage to the lining of the arteries. The company was founded by medical professional Doug Harrington, who has 30+ year experience commercializing over 200 academic discoveries.

About Boustead Securities, LLC

Boustead Securities, LLC (“Boustead”) is an investment banking firm that executes and advises on IPOs, mergers and acquisitions, capital raises and restructuring assignments in a wide array of industries, geographies and transactions, for a broad client base. Boustead’s core value proposition is the ability to create opportunity through innovative solutions and tenacious execution. With experienced professionals in the United States, Boustead’s team moves quickly and provides a broad spectrum of sophisticated financial advice and services. Boustead is a majority owned subsidiary of Boustead & Company Limited, a diversified non-bank financial institution. For more information, please visit www.boustead1828.com

Form CRS/Reg BI Disclaimer:

Boustead Securities, LLC, Sutter Securities Inc., and Sutter Securities Clearing,LLC (SSC) are registered with the Securities and Exchange Commission (SEC) as broker-dealers and are members of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC). Brokerage and investment advisory services and fees differ and it is important for you to understand these differences. Free and simple tools are available to research firms and financial professionals at Investor.gov/CRS, which also provides educational materials about broker-dealers, investment advisers, and investing. When we provide you with a recommendation, we have to act in your best interest and not put our interest ahead of yours. At the same time, the way we make money creates a conflict with your interests. Please strive to understand and ask us about these conflicts because they can affect the recommendations we provide you. There are many risks involved with investing. For Boustead Securities customers and clients, please see our Regulation Best Interest Relationship Guide on the Form CRS Reg BI page on our website at https://www.boustead1828.com/form-crs-reg-bi. For Sutter Securities’ and Sutter Securities Clearing’s customers and clients, please see the Form CRS on the website at https://suttersecurities.com/wp-content/uploads/2020/12/Sutter-Form-CRS-combined-121020.pdf. For FlashFunders’ visitors, you may review the Form CRS of Boustead Securities, Sutter Securities and Sutter Securities Clearing under the Form CRS section. Please also carefully review and verify the accuracy of the information you provide us on account applications, subscription documents and others.

Cautionary Statement Concerning Forward-Looking Statements

This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this document and other statements made from time to time by us or our representatives might not occur.

Announces Company Highlights and Developments at its Subsidiary, Particle, Inc.

ree

Boustead Securities, LLC (“Boustead”) client Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, through its patented and patent pending electromagnetic energy technology platforms, announced that it intends to list on a major national exchange, either NASDAQ or the NYSE, and is beginning the listing application process, with Boustead having been retained as advisor for the uplist.


Additionally, the Company highlighted recent accomplishments and issued its first public statement on the activities of its subsidiary corporation, Particle, Inc., which has, until now, been in stealth mode.


Uplist to a Major Exchange

With Boustead serving as an advisor, Know Labs has begun the process for an uplisting on a major national exchange: either NASDAQ or the NYSE. Listed companies must meet financial and liquidity requirements and satisfy corporate governance and disclosure requirements on both an initial and continuing basis.


The listing of the Company's common shares on a national exchange is subject to exchange approval and the ability of the Company to satisfy all applicable listing and regulatory requirements. While the Company intends to satisfy all of the applicable listing criteria, there is no assurance that a national exchange will approve the Company's application or that the Company will complete the listing as proposed.


Know Labs management believes uplisting to a national exchange will:

  • Provide additional opportunities to attract institutional and retail investors, allowing the Company to broaden its investor base in the United States and internationally;

  • Increase the visibility of the Company, its growth strategy, accomplishments and results to date;

  • Enable an aggressive growth strategy;

  • Increase liquidity of the Company's common shares; and

  • Raise the Company's overall profile and ultimately enhance shareholder value.


"We believe today's announcement is a significant milestone in our efforts to build Know Labs’ patented platform technology into an industry-leading provider of the next generation of continuous, real-time, non-invasive health monitoring solutions to address the unmet needs of millions of people facing challenging health conditions,” said Ron Erickson, Chairman and Founder of Know Labs. "In addition to increasing our visibility in the marketplace, the uplisting may improve the liquidity of our stock, broaden our institutional shareholder base, and augment long-term shareholder value."


Company Highlights

  • Received foundational patent on its Bio-RFID™ technology (US Patent No. 10,548,503 B2, entitled “Health Related Diagnostics Employing Spectroscopy in Radio/Microwave Frequency Band”) and continued work to expand its IP portfolio. Currently, the Company has more than 30 patents pending in their core focus on the use of electromagnetic energy to accurately identify and measure a broad range of in vivo biomolecules in the advancement of real-time, continuous health monitoring.

  • Closed a $5.7 million financing on favorable terms to support the advancement of the Company’s efforts to bring non-invasive glucose monitoring to the marketplace.

  • Developed relationships with internationally recognized clinical research institutions to perform laboratory-based validation testing to confirm internal test results.

  • Continued work on miniaturization of the Know Labs UBAND™ technology, internal testing and refinement of the use of its trade secret algorithms for exacting determination of blood glucose levels.

  • Formed the Particle, Inc. subsidiary to further expand and monetize Know Labs intellectual property.

  • Secured a team and resources to advance the Particle, Inc. commercialization activities.


Particle, Inc.

Formed in May 2020 and built upon the intellectual property of Know Labs, the independent team at Particle, Inc. has worked for the past 9 months to bring to market a disinfecting light bulb that can screw into existing fixtures in your home, office, or business. The Particle™ bulb is a hybrid light bulb that emits warm white light for everyday use and can kill viruses, bacteria, and germs, without harm to you or your family. Through internal preliminary testing, Particle, Inc. has confirmed the bulb’s efficacy in disinfecting common germs such as E. coli and Staphylococcus. A world renowned, CDC-regulated biosafety level-4 laboratory is currently testing the Particle bulb’s ability to deactivate SARS-CoV-2, the virus that causes COVID-19. Phil Bosua, Know Labs CEO and the inventor behind the first smart light bulb stated, “I had previously developed a light bulb that kills viruses and bacteria. When the coronavirus pandemic swept the world, we decided the time was right to truly revolutionize lighting as we know it. All of the internal testing we have conducted has been extremely positive and we expect results from an independent laboratory in the coming weeks. We brought together a talented team that is excited to introduce the Particle bulb to the market. It is the first of several products from Particle that I believe will make the space you inhabit safer for you and your family.”


ree

“We believe Particle is the world’s first hybrid light bulb that blends everyday light with disinfecting power, giving it not just a pleasing aesthetic but also valuable utility, opening the door to a cleaner life.” - Phil Bosua, Know Labs, Inc. CEO

About Know Labs, Inc.

Know Labs, Inc. is a public company whose shares trade under the stock symbol “KNWN.” The Company’s technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. The Company refers to its technology as Bio-RFID™. The Bio-RFID technology can be integrated into a variety of wearable, mobile or bench-top form factors. This patented and patent pending technology makes it possible to effectively conduct analyses that could only previously be performed by invasive and/or expensive and time-consuming lab-based tests. The Company’s first product will be the non-invasive UBAND™ Continuous Glucose Monitor (CGM). Those wishing to stay up to date on the developments at Know Labs can subscribe to the Company’s YouTube channel at this link. For more information, visit the company’s website at www.knowlabs.co


About Boustead Securities, LLC

Boustead Securities, LLC (“Boustead”) is an investment banking firm that executes and advises on IPOs, mergers and acquisitions, capital raises and restructuring assignments in a wide array of industries, geographies and transactions, for a broad client base. Boustead’s core value proposition is the ability to create opportunity through innovative solutions and tenacious execution. With experienced professionals in the United States, Boustead’s team moves quickly and provides a broad spectrum of sophisticated financial advice and services. Boustead is a majority owned subsidiary of Boustead & Company Limited, a diversified non-bank financial institution. For more information, please visit www.boustead1828.com


Form CRS/Reg BI Disclaimer:

Boustead Securities, LLC, Sutter Securities Inc., and Sutter Securities Clearing,LLC (SSC) are registered with the Securities and Exchange Commission (SEC) as broker-dealers and are members of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC). Brokerage and investment advisory services and fees differ and it is important for you to understand these differences. Free and simple tools are available to research firms and financial professionals at Investor.gov/CRS, which also provides educational materials about broker-dealers, investment advisers, and investing. When we provide you with a recommendation, we have to act in your best interest and not put our interest ahead of yours. At the same time, the way we make money creates a conflict with your interests. Please strive to understand and ask us about these conflicts because they can affect the recommendations we provide you. There are many risks involved with investing. For Boustead Securities customers and clients, please see our Regulation Best Interest Relationship Guide on the Form CRS Reg BI page on our website at https://www.boustead1828.com/form-crs-reg-bi. For Sutter Securities’ and Sutter Securities Clearing’s customers and clients, please see the Form CRS on the website at https://suttersecurities.com/wp-content/uploads/2020/12/Sutter-Form-CRS-combined-121020.pdf. For FlashFunders’ visitors, you may review the Form CRS of Boustead Securities, Sutter Securities and Sutter Securities Clearing under the Form CRS section. Please also carefully review and verify the accuracy of the information you provide us on account applications, subscription documents and others.

Cautionary Statement Concerning Forward-Looking Statements

This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this document and other statements made from time to time by us or our representatives might not occur.

bottom of page